AWM Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$291K Sell
1,189
-1,993
-63% -$464K 0.03% 98
2025
Q4
$659K Buy
3,182
+5
+0.2% +$989 0.06% 63
2025
Q3
$589K Sell
3,177
-45
-1% -$7.71K 0.05% 65
2025
Q2
$492K Buy
3,222
+103
+3% +$15.8K 0.05% 68
2025
Q1
$517K Buy
3,119
+428
+16% +$67K 0.06% 63
2024
Q4
$389K Buy
2,691
+14
+0.5% +$2.17K 0.05% 73
2024
Q3
$434K Buy
2,677
+42
+2% +$6.69K 0.05% 68
2024
Q2
$385K Buy
2,635
+60
+2% +$8.92K 0.06% 65
2024
Q1
$407K Hold
2,575
0.07% 64
2023
Q4
$404K Sell
2,575
-268
-9% -$41.1K 0.07% 61
2023
Q3
$443K Buy
2,843
+124
+5% +$20.5K 0.09% 56
2023
Q2
$450K Sell
2,719
-47
-2% -$7.59K 0.11% 49
2023
Q1
$429K Sell
2,766
-24
-0.9% -$3.88K 0.12% 51
2022
Q4
$493K Buy
2,790
+124
+5% +$21.4K 0.17% 49
2022
Q3
$473K Buy
2,666
+573
+27% +$97K 0.16% 45
2022
Q2
$372K Sell
2,093
-34
-2% -$6.06K 0.18% 44
2022
Q1
$377K Sell
2,127
-12
-0.6% -$2.04K 0.23% 40
2021
Q4
$366K Sell
2,139
-225
-10% -$36.8K 0.28% 41
2021
Q3
$384K Buy
+2,364
New +$403K 0.29% 45

Other funds holding JNJ

AWM Capital's JNJ Position: Q1 2026 in Review

AWM Capital reduced its Johnson & Johnson (JNJ) stake by 63% in Q1 2026, selling an estimated $464K and leaving 1,189 shares worth $291K. The position accounts for 0.03% of the portfolio, ranked #98.

AWM Capital first reported a position in JNJ in Q3 2021 and has held it in 19 quarters since. The position peaked at $659K in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • AWM Capital held 1,189 shares of Johnson & Johnson worth $291K as of Q1 2026.
  • AWM Capital sold 1,993 Johnson & Johnson shares in Q1 2026, an estimated $464K.
  • Johnson & Johnson made up 0.03% of AWM Capital's portfolio in Q1 2026, its #98 holding.
  • AWM Capital first reported a position in Johnson & Johnson in Q3 2021 and has held it in 19 quarters since.
  • AWM Capital's Johnson & Johnson position peaked at $659K in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on AWM Capital's 13F filing for Q1 2026, filed 12 May 2026.